Published in Am J Obstet Gynecol on August 01, 1988
Tobacco Smoke and Lead Exposure During Pregnancy | NCT00514280
Molecular epidemiologic research on the effects of environmental pollutants on the fetus. Environ Health Perspect (1999) 2.28
Determinants of passive smoking in children in Edinburgh, Scotland. Am J Public Health (1992) 2.17
Methods for quantification of exposure to cigarette smoking and environmental tobacco smoke: focus on developmental toxicology. Ther Drug Monit (2009) 1.89
Biomarkers in maternal and newborn blood indicate heightened fetal susceptibility to procarcinogenic DNA damage. Environ Health Perspect (2004) 1.80
Misclassification rates for current smokers misclassified as nonsmokers. Am J Public Health (1998) 1.78
The effect of paternal smoking on the birthweight of newborns whose mothers did not smoke. Group Health Medical Associates. Am J Public Health (1994) 1.71
Children's health and the environment: public health issues and challenges for risk assessment. Environ Health Perspect (2004) 1.61
Association of prenatal maternal or postnatal child environmental tobacco smoke exposure and neurodevelopmental and behavioral problems in children. Environ Health Perspect (1999) 1.57
Passive and active maternal smoking as measured by serum cotinine: the effect on birthweight. Am J Public Health (1995) 1.52
Environmental tobacco smoke and low birth weight: a hazard in the workplace? Environ Health Perspect (1999) 1.43
Application of biologic markers to studies of environmental risks in children and the developing fetus. Environ Health Perspect (1995) 1.34
Fetal growth and length of gestation in relation to prenatal exposure to environmental tobacco smoke assessed by hair nicotine concentration. Environ Health Perspect (2001) 1.32
Maternal smoking during pregnancy and postnatal exposure to environmental tobacco smoke as predisposition factors to acute respiratory infections. Environ Health Perspect (1997) 1.26
Environmental tobacco smoke exposure among pregnant women: impact on fetal biometry at 20-24 weeks of gestation and newborn child's birth weight. Int Arch Occup Environ Health (2003) 1.20
Passive smoking by pregnant women and fetal growth. J Epidemiol Community Health (1991) 1.09
The exposure of nonsmoking and smoking mothers to environmental tobacco smoke during different gestational phases and fetal growth. Environ Health Perspect (2002) 0.99
Nutrient intakes during pregnancy: the influence of smoking status and age. J Epidemiol Community Health (2000) 0.85
Relation between cotinine in the urine and indices based on self-declared smoking habits. Environ Health Prev Med (2002) 0.83
Maternal thyroid deficiency during pregnancy and subsequent neuropsychological development of the child. N Engl J Med (1999) 11.19
Therapeutic trial of trimethoprim as a potentiator of sulphonamides in gonorrhoea. Br J Vener Dis (1967) 10.52
Maternal serum screening for Down's syndrome in early pregnancy. BMJ (1988) 8.65
Association between exposure to environmental tobacco smoke and exacerbations of asthma in children. N Engl J Med (1993) 5.56
Prenatal screening for Down's syndrome with use of maternal serum markers. N Engl J Med (1992) 5.21
Inducible expression vectors incorporating the Escherichia coli atpE translational initiation region. Gene (1987) 3.46
Is it time for population-based prenatal screening for fragile-X? Lancet (1993) 3.24
Cigarette smoking and serum lipid and lipoprotein concentrations: an analysis of published data. BMJ (1989) 2.96
Improved 125I radioimmunoassay for cotinine by selective removal of bridge antibodies. Clin Chem (1985) 2.79
Prenatal screening for trisomy 18 in the second trimester. Prenat Diagn (1990) 2.66
Maternal serum unconjugated oestriol as an antenatal screening test for Down's syndrome. Br J Obstet Gynaecol (1988) 2.62
Reducing the need for amniocentesis in women 35 years of age or older with serum markers for screening. N Engl J Med (1994) 2.56
Maternal thyroid deficiency and pregnancy complications: implications for population screening. J Med Screen (2000) 2.47
VEGF and VEGF-C: specific induction of angiogenesis and lymphangiogenesis in the differentiated avian chorioallantoic membrane. Dev Biol (1997) 2.43
Low second trimester maternal serum unconjugated oestriol in pregnancies with Down's syndrome. Br J Obstet Gynaecol (1988) 2.40
Cotinine-assisted intervention in pregnancy to reduce smoking and low birthweight delivery. Br J Obstet Gynaecol (1991) 1.96
The sodium, potassium, and water contents of red blood cells of healthy human adults. J Clin Invest (1966) 1.82
The eukaryotic mRNA decapping protein Dcp1 interacts physically and functionally with the eIF4F translation initiation complex. EMBO J (2000) 1.70
Translational initiation frequency of atp genes from Escherichia coli: identification of an intercistronic sequence that enhances translation. EMBO J (1985) 1.67
Cooperative modulation by eIF4G of eIF4E-binding to the mRNA 5' cap in yeast involves a site partially shared by p20. EMBO J (1998) 1.63
An unsuccessful cotinine-assisted intervention strategy to reduce environmental tobacco smoke exposure during infancy. Am J Dis Child (1992) 1.61
Analysis of eukaryotic mRNA structures directing cotranslational incorporation of selenocysteine. Nucleic Acids Res (1996) 1.60
Risk-based prenatal screening for trisomy 18 using alpha-fetoprotein, unconjugated oestriol and human chorionic gonadotropin. Prenat Diagn (1995) 1.60
Stabilization of eukaryotic initiation factor 4E binding to the mRNA 5'-Cap by domains of eIF4G. J Biol Chem (2000) 1.58
Repressor binding to a dorsal regulatory site traps human eIF4E in a high cap-affinity state. EMBO J (1999) 1.56
Initiation factor eIF-4E of Saccharomyces cerevisiae. Distribution within the cell, binding to mRNA, and consequences of its overproduction. J Biol Chem (1994) 1.56
Properties of an entropy-based signal receiver with an application to ultrasonic molecular imaging. J Acoust Soc Am (2007) 1.54
Proteins binding to 5' untranslated region sites: a general mechanism for translational regulation of mRNAs in human and yeast cells. Mol Cell Biol (1994) 1.49
Joint entropy of continuously differentiable ultrasonic waveforms. J Acoust Soc Am (2013) 1.49
The impact of preconception counseling on pregnancy outcomes. The experience of the Maine Diabetes in Pregnancy Program. Diabetes Care (1993) 1.47
Inhibition of translational initiation in the yeast Saccharomyces cerevisiae as a function of the stability and position of hairpin structures in the mRNA leader. J Biol Chem (1993) 1.43
Prenatal screening for open neural-tube defects in Maine. N Engl J Med (1999) 1.42
The Mycobacterium tuberculosis 38-kDa antigen: overproduction in Escherichia coli, purification and characterization. Gene (1992) 1.41
Maternal serum alpha-fetoprotein, age, and Down syndrome risk. Am J Obstet Gynecol (1987) 1.39
Second trimester screening for Down's syndrome using maternal serum dimeric inhibin A. J Med Screen (1998) 1.38
A quantitative molecular model for modulation of mammalian translation by the eIF4E-binding protein 1. J Biol Chem (2001) 1.37
Use of serum cotinine to assess the accuracy of self reported non-smoking. Br Med J (Clin Res Ed) (1986) 1.36
The yeast transcription factor genes YAP1 and YAP2 are subject to differential control at the levels of both translation and mRNA stability. Nucleic Acids Res (1998) 1.36
Eukaryotic selenocysteine incorporation follows a nonprocessive mechanism that competes with translational termination. J Biol Chem (2000) 1.33
Proton conduction by subunit a of the membrane-bound ATP synthase of Escherichia coli revealed after induced overproduction. EMBO J (1985) 1.33
Cigarette consumption and serum cotinine in relation to birthweight. Br J Obstet Gynaecol (1987) 1.32
Population screening for haemochromatosis: a unifying analysis of published intervention trials. J Med Screen (1996) 1.31
Post-termination ribosome interactions with the 5'UTR modulate yeast mRNA stability. EMBO J (1999) 1.30
Population screening for haemochromatosis: expectations based on a study of relatives of symptomatic probands. J Med Screen (1996) 1.29
Hereditary haemochromatosis mutation frequencies in the general population. J Med Screen (1998) 1.27
Sequence and expression of the gene encoding the respiratory nitrous-oxide reductase from Paracoccus denitrificans. New and conserved structural and regulatory motifs. Eur J Biochem (1993) 1.26
Young maternal age and smoking during pregnancy as risk factors for gastroschisis. Teratology (1993) 1.24
Application of Renyi entropy for ultrasonic molecular imaging. J Acoust Soc Am (2009) 1.23
Determination of nicotine and cotinine in human serum and urine: an interlaboratory study. Toxicol Lett (1987) 1.23
Inhibition of translational initiation in Saccharomyces cerevisiae by secondary structure: the roles of the stability and position of stem-loops in the mRNA leader. Mol Microbiol (1993) 1.18
The influence of 5'-secondary structures upon ribosome binding to mRNA during translation in yeast. J Biol Chem (1993) 1.16
A fully modular vector system for the optimization of gene expression in Escherichia coli. Plasmid (1991) 1.16
The evaluation of histamine antagonists in man. Eur J Clin Pharmacol (1971) 1.15
Reference distributions for the negative acute-phase serum proteins, albumin, transferrin and transthyretin: a practical, simple and clinically relevant approach in a large cohort. J Clin Lab Anal (1999) 1.14
Identification and developmental expression of a 5'-3' exoribonuclease from Drosophila melanogaster. Mech Dev (1998) 1.11
Refinements in managing maternal weight adjustment for interpreting prenatal screening results. Prenat Diagn (1996) 1.11
Analysis of the catalytic mechanism of a fungal lipase using computer-aided design and structural mutants. Protein Eng (1996) 1.10
Enhancement of translational efficiency by the Escherichia coli atpE translational initiation region: its fusion with two human genes. Gene (1986) 1.10
Disruption of ribosomal scanning on the 5'-untranslated region, and not restriction of translational initiation per se, modulates the stability of nonaberrant mRNAs in the yeast Saccharomyces cerevisiae. J Biol Chem (1997) 1.10
Characterization of the in vivo phosphorylation sites of the mRNA.cap-binding complex proteins eukaryotic initiation factor-4E and p20 in Saccharomyces cerevisiae. J Biol Chem (1995) 1.07
Prenatal screening for cystic fibrosis. Lancet (1994) 1.07
The urinary excretion of human chorionic gonadotrophin in normal and abnormal pregnancy. J Obstet Gynaecol Br Commonw (1966) 1.07
Mutants of eukaryotic initiation factor eIF-4E with altered mRNA cap binding specificity reprogram mRNA selection by ribosomes in Saccharomyces cerevisiae. J Biol Chem (1996) 1.07
Translational repression by the human iron-regulatory factor (IRF) in Saccharomyces cerevisiae. Nucleic Acids Res (1993) 1.06
Environmental tobacco smoke exposure during infancy. Am J Public Health (1990) 1.06
Lipoprotein(a) as a risk factor for ischemic heart disease: metaanalysis of prospective studies. Clin Chem (1998) 1.06
Real-time calculation of a limiting form of the Renyi entropy applied to detection of subtle changes in scattering architecture. J Acoust Soc Am (2009) 1.06
The mechanism of translational coupling in Escherichia coli. Higher order structure in the atpHA mRNA acts as a conformational switch regulating the access of de novo initiating ribosomes. J Biol Chem (1994) 1.06
Prospective intervention trial of a screening protocol to identify fetal trisomy 18 using maternal serum alpha-fetoprotein, unconjugated oestriol, and human chorionic gonadotropin. Prenat Diagn (1992) 1.05
The reference range and within-person variability of thyroid stimulating hormone during the first and second trimesters of pregnancy. J Med Screen (2004) 1.05
Relation between maternal weight and serum alpha-fetoprotein concentration during the second trimester. Clin Chem (1981) 1.04
The measurement of sodium concentration in human red blood cells. J Gen Physiol (1966) 1.02
The effect of smoking in pregnancy on maternal serum alpha-fetoprotein, unconjugated oestriol, human chorionic gonadotrophin, progesterone and dehydroepiandrosterone sulphate levels. Br J Obstet Gynaecol (1990) 1.00
Simultaneous fetal and maternal cotinine levels in pregnant women smokers. Am J Obstet Gynecol (1993) 1.00
Evidence for liver disease preceding amino acid abnormalities in hereditary tyrosinemia. N Engl J Med (1983) 0.99
Cotinine analytical workshop report: consideration of analytical methods for determining cotinine in human body fluids as a measure of passive exposure to tobacco smoke. Environ Health Perspect (1990) 0.99
Exposure to environmental tobacco smoke measured by cotinine 125I-radioimmunoassay. Clin Chem (1989) 0.99
Measurements of s-p coordinates during the development of Euglena chloroplasts. Biochim Biophys Acta (1968) 0.98
Screening of maternal serum for fetal Down's syndrome in the first trimester. N Engl J Med (1998) 0.97